Skip to main content
PCAS logo

PCAS — Investor Relations & Filings

Ticker · PCA ISIN · FR0000053514 LEI · 9695009WMW72CD0E3W90 PA Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2023-12-18 Delisting Announcement
Country FR France
Listing PA PCA

About PCAS

https://www.pcas.com/

PCAS is a supplier of chemical components for the pharmaceutical industry. The company's product portfolio includes Active Pharmaceutical Ingredients (APIs), excipients, and intermediates. These materials are used in the development and manufacturing of pharmaceutical products. As a certified supplier, PCAS serves the life sciences market.

Recent filings

Filing Released Lang Actions
PCAS : Réalisation de l’augmentation de capital de PCAS d’un montant de 200 millions d’euros, après retrait obligatoire des titres de la société
Delisting Announcement Classification · 99% confidence The document is a formal announcement dated December 18, 2023, detailing a significant financial event for PCAS. The key headline is 'Réalisation de l'augmentation de capital de PCAS d'un montant de 200 millions d'euros' (Completion of the capital increase of PCAS for an amount of 200 million euros). It explicitly states that the capital increase was fully subscribed by the sole shareholder, Seqens, following a mandatory buy-out. This action directly relates to changes in the company's capital structure and financing activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific, completed financing transaction.
2023-12-18 French
Franchissement de seuil
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to "Declaration of crossing a threshold (Article L. 233-7 of the Commercial Code)". It explicitly states that the company Seqens crossed the 95% threshold of PCAS capital on November 3, 2023, detailing the number of shares and voting rights. This type of filing, reporting changes in significant share ownership or control thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is short and official, confirming a change in ownership percentage.
2023-11-08 French
PCAS - Mise à disposition de la note en réponse et des informations relatives aux caractéristiques, notamment juridiques, financières et comptables de la société dans le cadre de l’OPAS
Report Publication Announcement Classification · 98% confidence The document is a 'COMMUNIQUE' dated November 2, 2023, relating to the 'MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LA SOCIETE PCAS' within the context of a Simplified Public Purchase Offer (OPA). It explicitly states that the 'note en réponse' (response note) and other related information have been filed with the AMF and are made available to the public today, providing links and contact information for obtaining them. This structure—announcing the availability of official documents related to a corporate action (here, a takeover bid/tender offer) rather than being the full report itself—strongly indicates a Report Publication Announcement (RPA). The document is short (3372 characters) and serves to inform the public that the required documentation is now accessible, fitting the 'MENU VS MEAL' rule for RPA.
2023-11-02 French
PCAS : chiffre d’affaires au 30 septembre 2023
Earnings Release Classification · 99% confidence The document explicitly announces the 'CHIFFRE D'AFFAIRES AU 30 SEPTEMBRE 2023' (Revenue as of September 30, 2023) and provides detailed consolidated financial figures for the first nine months of 2023 compared to 2022. This content structure—presenting key financial metrics for a specific reporting period (9 months ending Sept 30) immediately following the period close—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since the text provides the core financial highlights and commentary ('Synthèse Pharmaceutique', 'Chimie Fine de Spécialités', 'Perspectives') without the full, detailed financial statements typically found in a comprehensive Interim Report (IR), it aligns best with the definition of an Earnings Release (ER), which focuses on initial results and key highlights. The document is dated October 24, 2023, which is typical for a Q3 earnings announcement. 9M 2023
2023-10-24 French
PCAS: Net Sales as of September 30, 2023
Earnings Release Classification · 99% confidence The document explicitly announces 'consolidated net sales as of September 30, 2023' and provides detailed financial tables comparing the 9 months of 2023 results against 2022. This content is characteristic of a periodic financial results announcement, specifically for a nine-month period (Interim Report). However, the text structure is brief, focusing on key figures and a brief outlook, and it is presented as a press release announcing the figures, rather than the comprehensive, audited report itself. The key indicator is the line: 'PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2023.' This suggests an initial release of results. Since the period covered is 9 months (Interim), the most appropriate classification is Interim / Quarterly Report (IR). If it were purely an announcement stating the full report was attached, it would be RPA, but this document contains the core data itself. 9M 2023
2023-10-24 English
Franchissement de seuils
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuils (article L. 233-7 du code de commerce)" and details a change in the shareholding percentage (crossing thresholds of 90% and 95% of capital and voting rights) held by Seqens SAS in PCAS. This type of mandatory disclosure regarding significant changes in ownership thresholds is a notification of major shareholding changes. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and is a direct regulatory filing, not an announcement of a larger report.
2023-10-17 French

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.